Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-06-14
2011-06-14
Duffy, Patricia A (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S391100, C436S548000, C435S070210
Reexamination Certificate
active
07960518
ABSTRACT:
The present invention provides human binding molecules specifically binding to enterococci and having killing activity against enterococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting fromEnterococcus.
REFERENCES:
patent: 5696108 (1997-12-01), Heath, Jr. et al.
patent: 6265150 (2001-07-01), Terstappen et al.
patent: 6908994 (2005-06-01), Rich et al.
patent: 7244430 (2007-07-01), Throsby et al.
patent: 7537764 (2009-05-01), Throsby et al.
patent: 2005/0180986 (2005-08-01), Rich et al.
patent: 2006/0002939 (2006-01-01), Fischer et al.
patent: 2009/0104204 (2009-04-01), Throsby et al.
patent: WO 84/03564 (1984-09-01), None
patent: WO 93/09872 (1993-05-01), None
patent: WO 98/15833 (1998-04-01), None
patent: WO 98/57994 (1998-12-01), None
patent: WO 99/18996 (1999-04-01), None
patent: WO 00/63403 (2000-10-01), None
patent: WO 02/103012 (2002-12-01), None
patent: WO 03/059259 (2003-07-01), None
patent: WO 03/059260 (2003-07-01), None
patent: WO 03/072607 (2003-09-01), None
patent: WO 2004/043405 (2004-05-01), None
patent: WO 2005/103084 (2005-11-01), None
patent: WO 2005-118644 (2005-12-01), None
patent: WO 2006/067122 (2006-06-01), None
patent: WO 2007/141278 (2007-12-01), None
Campbell, Monoclonal Antibody Technology, Elsevier Science Publishing Co., 1984, Chapter 1, pp. 1-32.
van der Woude, Clinical Microbiology Reviews, 17(3):581-611, Jul. 2004.
Chen et al (The EMBO Journal, 14(12:2784-2794, 1995).
Kussie et al, (J. Immunology, 152:146-152, 1994).
Dorland's Medical Dictionary for Healthcare Consumers; definition of infection one page (http://www.mercksource.com/pp/us/cns/cns—hl—dorlands—split.jsp?pg=/ppdocs/us/common/dorlands/dorland/four/000053439.htm).
Stedman's Online Medical Dictionary , definition of infection one page.
PCT International Search Report, PCT/EP2007/055535, dated Jun. 5, 2007.
Bowie et al., Science, 1990, pp. 1306-1310, vol. 247.
Cruse et al., Illustrated Dict. of Immunology, 2nded., CRC Press, 2003, p. 46.
Brown et al., J. Immunol., 1996, pp. 3285-3291, vol. 156.
Kussie et al., J. Immunol., 1994, pp. 146-152, vol. 152.
PCT International Search Report, PCT/EP2007/055527, dated Jan. 29, 2008.
De Kruif Cornelis Adriaan
Kramer Robert Arjen
Throsby Mark
Crucell Holland B.V.
Duffy Patricia A
TraskBritt P.C.
LandOfFree
Human binding molecules having killing activity against... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human binding molecules having killing activity against..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human binding molecules having killing activity against... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2710907